Regorafenib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: Instructions Regorafenib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Regorafenib included in the composition |
Prices in pharmacies |
Stivarga | 1768-1810.3€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% Calcium folinate
- 50% Ramucirumab
- 42% Capecitabine
- 35% Epirubicin
- 33% Nimustine
- 32% Pentagastrin
- 31% Lomustine
- 30% Pazopanib
- 29% Folinic acid
- 28% Tegafur+Uracil [Tegafur]
- 28% Tegafur
- 28% Oxaliplatin
- 27% Aflibercept
- 27% Cabozantinib
- 27% Tegafur+Gimeracil+Oteracil [Tegafur]
- 25% Fluorouracil
- 25% Irinotecan
- 25% Nintedanib
- 24% Mitomycin
- 24% Inonotus Obliquus
- 24% Sorafenib
- 22% Everolimus
- 22% Sarcolysin
- 22% Topotecan
- 22% Melphalan
- 20% Trametinib
- 20% Lorlatinib
- 19% Bevacizumab
- 19% Abemaciclib
- 18% Palbociclib
- 17% Rabeprazole
- 17% Pantoprazole
- 17% Atezolizumab
- 17% Doxorubicin
- 17% Docetaxel
- 16% Lansoprazole
- 16% Ibrutinib
- 15% Vandetanib
- 15% Paclitaxel
- 15% Hydrazine sulfate
- 15% Ribociklib
- 15% Cetuximab
- 14% Osimertinib
- 14% Afatinib
- 14% Vindesine
- 14% Ceritinib
- 13% Folic acid
- 13% Imatinib
- 13% Dasatinib
- 13% Akalabrutinib
Learn more about the selection of analogues
- The drug has «Regorafenib» 51 analog by action, the most similar - Calcium folinate .
- Medical online service has selected the best substitutes for Regorafenib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Regorafenib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.